Literature DB >> 8383056

Impaired G-proteins and cyclic nucleotide phosphodiesterase activity in T-lymphocytes from patients with sarcoidosis.

G Nemoz1, A F Prigent, R Aloui, G Charpin, F Gormand, H Gallet, A Desbos, N Biot, M Perrin-Fayolle, M Lagarde.   

Abstract

Among the various immune abnormalities which characterize active sarcoidosis, a low proliferative response of peripheral blood lymphocytes to mitogenic lectins has long been observed. Since membrane-associated G-proteins are very likely to be crucial elements in lectin signal transduction, we investigated the binding of 5'-guanylylimidodiphosphate (GppNHp), a non hydrolyzable GTP analogue, to blood total lymphocyte membranes and to blood T-lymphocyte membranes from patients with active sarcoidosis, and from healthy control subjects. GppNHp binding was markedly decreased in peripheral cells from patients with sarcoidosis as compared to controls, suggesting the occurrence of a defect at the level of G-protein(s). A further characterization of G-proteins in these cells by means of ADP-ribose-labelling in the presence of bacterial toxins brought forward a significant decrease in the labelling of a 40 kDa protein, the major pertussis toxin substrate, in membranes from sarcoid patients, while the labelling of the major 44 kDa cholera toxin substrate proved to be unchanged with respect to control membranes. It is hypothesized that, in sarcoid lymphocytes, a defect in the negative control of adenylate cyclase mediated by the inhibitory G-protein Gi, prevents the lowering of cAMP necessary to normal mitogenic response of blood lymphocytes to stimulation. cAMP degradation by the specialized enzyme phosphodiesterase constitutes another critical step in the control of cAMP levels. Both cAMP and cGMP phosphodiesterase activities were found decreased in blood total lymphocyte preparations from sarcoid patients. With purified T-cells, although the mean cAMP and cGMP phosphodiesterase activities from sarcoid patients were found more markedly decreased with respect to healthy donors, only the decrease in cGMP phosphodiesterase was found statistically significant. The role these defects in cyclic nucleotide degradation potentially play in the disturbance of blood lymphocytes response associated with sarcoidosis is discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8383056     DOI: 10.1111/j.1365-2362.1993.tb00713.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  4 in total

1.  Imbalance of pro- and anti-inflammatory cytokines in pulmonary sarcoidosis.

Authors:  J Müller-Quernheim
Journal:  Mediators Inflamm       Date:  1996       Impact factor: 4.711

Review 2.  Immunopathogenesis of granulomas in chronic autoinflammatory diseases.

Authors:  Wilhelmina Maria Cornelia Timmermans; Jan Alexander Michael van Laar; Petrus Martinus van Hagen; Menno Cornelis van Zelm
Journal:  Clin Transl Immunology       Date:  2016-12-16

3.  Whole exome sequencing in three families segregating a pediatric case of sarcoidosis.

Authors:  Alain Calender; Pierre Antoine Rollat Farnier; Adrien Buisson; Stéphane Pinson; Abderrazzaq Bentaher; Serge Lebecque; Harriet Corvol; Rola Abou Taam; Véronique Houdouin; Claire Bardel; Pascal Roy; Gilles Devouassoux; Vincent Cottin; Pascal Seve; Jean-François Bernaudin; Clarice X Lim; Thomas Weichhart; Dominique Valeyre; Yves Pacheco; Annick Clement; Nadia Nathan
Journal:  BMC Med Genomics       Date:  2018-03-06       Impact factor: 3.063

4.  Pertussis toxin inhibits activation-induced cell death of human thymocytes, pre-B leukemia cells and monocytes.

Authors:  R Ramírez; J Carracedo; N Zamzami; M Castedo; G Kroemer
Journal:  J Exp Med       Date:  1994-09-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.